We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+32.54%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$669M
AUM Growth
+$53.6M
Cap. Flow
-$52.3M
Cap. Flow %
-7.82%
Top 10 Hldgs %
10.74%
Holding
352
New
111
Increased
43
Reduced
68
Closed
113

Top Sells

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$8.04M
2
RXST icon
RxSight
RXST
+$5.75M
3
ASTS icon
AST SpaceMobile
ASTS
+$5.7M
4
ONTO icon
Onto Innovation
ONTO
+$5.68M
5
VECO icon
Veeco
VECO
+$5.21M

Sector Composition

Rank Sector Weight
1 Healthcare 26.67%
2 Technology 19.8%
3 Industrials 17.72%
4 Financials 12.74%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IESC icon
101
IES Holdings
IESC
$15.3B
$3.52M 0.53%
17,622
-3,255
-16% -$528K
GERN icon
102
Geron
GERN
$1.01B
$3.39M 0.51%
745,614
+1,344
+0.2% +$6.11K
CDNA icon
103
CareDx
CDNA
$2.32B
$3.37M 0.5%
+107,890
New +$2.68M
BHE icon
104
Benchmark Electronics
BHE
$2.96B
$3.35M 0.5%
+75,600
New +$3.16M
EWTX icon
105
Edgewise Therapeutics
EWTX
$4.78B
$3.34M 0.5%
+125,184
New +$2.49M
COHR icon
106
Coherent
COHR
$65.4B
$3.32M 0.5%
37,382
-19,363
-34% -$1.45M
AGIO icon
107
Agios Pharmaceuticals
AGIO
$1.91B
$3.3M 0.49%
74,273
+131
+0.2% +$5.95K
RARE icon
108
Ultragenyx Pharmaceutical
RARE
$2.54B
$3.26M 0.49%
+58,631
New +$2.99M
GRND icon
109
Grindr
GRND
$3.05B
$3.25M 0.49%
272,146
+475
+0.2% +$5.63K
BCO icon
110
Brink's
BCO
$4.65B
$3.23M 0.48%
27,942
-18,688
-40% -$1.98M
RVMD icon
111
Revolution Medicines
RVMD
$42.1B
$3.23M 0.48%
71,210
-29,813
-30% -$1.3M
CPRX
112
DELISTED
Catalyst Pharmaceutical
CPRX
$3.21M 0.48%
+161,249
New +$2.99M
DTM icon
113
DT Midstream
DTM
$13.6B
$3.2M 0.48%
40,680
-17,139
-30% -$1.28M
BRC icon
114
Brady Corp
BRC
$4.63B
$3.19M 0.48%
41,686
-13,538
-25% -$964K
PPC icon
115
Pilgrim's Pride
PPC
$6.56B
$3.19M 0.48%
69,304
-29,865
-30% -$1.26M
VCTR icon
116
Victory Capital Holdings
VCTR
$6.68B
$3.18M 0.48%
57,476
-22,458
-28% -$1.16M
AHR icon
117
American Healthcare REIT
AHR
$10.5B
$3.18M 0.48%
+121,990
New +$2.38M
AMSC icon
118
American Superconductor
AMSC
$1.59B
$3.14M 0.47%
133,185
-70,741
-35% -$1.63M
CRDO icon
119
Credo Technology Group
CRDO
$43B
$3.12M 0.47%
101,331
-67,209
-40% -$2M
LMAT icon
120
LeMaitre Vascular
LMAT
$1.85B
$3.06M 0.46%
32,974
+11
+0% +$953
ATI icon
121
ATI
ATI
$30.5B
$3.05M 0.46%
45,649
-23,215
-34% -$1.44M
PI icon
122
Impinj
PI
$5.25B
$3.04M 0.46%
14,063
-13,566
-49% -$2.3M
CECO icon
123
Ceco Environmental
CECO
$4.01B
$3.03M 0.45%
107,321
-54,234
-34% -$1.53M
CRNX icon
124
Crinetics Pharmaceuticals
CRNX
$8.9B
$2.92M 0.44%
57,216
+37
+0.1% +$1.91K
TPC
125
Tutor Perini Cor
TPC
$5.04B
$2.88M 0.43%
106,085
-67,672
-39% -$1.55M

Similar funds

EAM Investors's Q3 2024 Portfolio in Review

As of Q3 2024, EAM Investors held 352 positions worth $669M, up 8.7% from $615M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $52.3M in Q3 2024, closing 113 positions and reducing 68 holdings. Its most notable exit was Super Micro Computer, an estimated $8.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in The Ensign Group worth $6.17M.

  • EAM Investors's largest Q3 2024 buy was The Ensign Group: 42,931 shares worth $6.17M.
  • EAM Investors added most to Sprouts Farmers Market in Q3 2024, an estimated $3.69M increase.
  • EAM Investors's biggest Q3 2024 reduction was AST SpaceMobile, cutting an estimated $5.7M.
  • EAM Investors fully exited Super Micro Computer in Q3 2024, selling an estimated $8.04M.
  • EAM Investors's ten largest holdings make up 11% of its $669M portfolio in Q3 2024.
  • EAM Investors opened 111 new positions and closed 113 in Q3 2024.
  • EAM Investors's portfolio value rose 8.7% quarter-over-quarter to $669M.

Based on EAM Investors's 13F filing for Q3 2024, filed 13 Nov 2024.